What is CPCI's market capitalization?

Kahira Pharmaceuticals & Chemical Industries Co. has a market capitalization of about EGP 8.96B.

Does CPCI pay dividends?

Yes — Kahira Pharmaceuticals & Chemical Industries Co. paid EGP 2 per share for fiscal 2019, a dividend yield of 0.33% at the last price.

What is CPCI's P/E ratio?

Kahira Pharmaceuticals & Chemical Industries Co. trades at a trailing price-to-earnings ratio of 16.16.

What sector is Kahira Pharmaceuticals & Chemical Industries Co. in?

Kahira Pharmaceuticals & Chemical Industries Co. is listed on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector.

Where can I track CPCI?

This Starta Markets page shows Kahira Pharmaceuticals & Chemical Industries Co.'s EGX quote (delayed 15 minutes), key statistics, financial statements, dividends, technicals and news, in Arabic and English.

Kahira Pharmaceuticals & Chemical Industries Co. (CPCI) Share Price — EGX

EGP 599.7+0.3%Indicator average: +0.51 (−1 to +1)

Kahira Pharmaceuticals & Chemical Industries Co. (CPCI) trades on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector. Last updated 28 Oct 2026, 12:50 (Cairo time).

What is Kahira Pharmaceuticals & Chemical Industries Co.’s share price today? CPCI last traded at EGP 599.7 (+0.30% on the day), for a market value of EGP 8.96 billion, a P/E of 16.16 and a dividend yield of 0.33%. Its 52-week range is EGP 235 to 644.

CPCI price performance

1W: +1.3%
1M: +6.6%
3M: +28.0%
6M: +86.7%
YTD: +122.4%
1Y: +122.4%
5Y: +1573.5%

Price change from EGX closing prices, adjusted for recorded splits and bonus issues; cash dividends are not included. A period that spans an unexplained price jump is not shown. Past performance does not indicate future results.

About Kahira Pharmaceuticals & Chemical Industries Co.

Kahira Pharmaceuticals & Chemical Industries Co. engages in the manufacture and distribution of pharmaceutical products for human and veterinary use, cosmetics and pesticides, and other chemical substances and related products. Its products include analgesics, antibiotics, antidepressants, antihistamines, dermatological, endocrine drugs, gastrointestinal drugs, ophthalmic, pulmonic, and urinary antiseptics. The company was founded in 1962 and is headquartered in Cairo, Egypt.

Industry:: Pharmaceuticals: Major
Employees:: 1,730
CEO:: Yasser Ahmed Farghaly Mohammad
ISIN:: EGS38391C016
Website:: www.kahira-pharma.com

CPCI key statistics

Last price: EGP 599.7
Previous close: EGP 589.94
Day change: 0.3%
52-week range: EGP 235 – 644
Volume: 4,819
Shares outstanding: 14.93M
Free float: 30%
Market cap: EGP 8.96B
P/E (trailing): 16.16
P/B: 6.9
Dividend yield (FY 2019): 0.33%
EPS (TTM): EGP 37
Revenue (TTM): EGP 2.52B
Net income (TTM): EGP 552.54M
ROE: 42.69%
Book value / share: EGP 86.66
Beta (1Y): 0.14
50-day MA: EGP 564.27
200-day MA: EGP 388.74
RSI (14): 59.25

Data as of 28 Oct 2026, 12:50 (Cairo time). EGX market data; financial statements from company disclosures. Prices are delayed 15 minutes during EGX trading hours (Sun–Thu).

Compare with other Health Care & Pharmaceuticals stocks

Key terms behind the CPCI figures

Market Capitalization: Market capitalization is the total market value of a company’s outstanding shares, calculated as the share price multiplied by the number of issued shares. It is the standard measure used to rank the size of listed companies and to weight them in indices such as the EGX 30. Market cap changes continuously as the share price moves.
Price-to-Earnings (P/E) Ratio: The price-to-earnings ratio divides a company’s share price by its earnings per share, showing how many pounds investors pay for each pound of annual profit. It is one of the most widely used valuation multiples for comparing listed companies within the same sector. A trailing P/E uses reported earnings, while a forward P/E uses forecast earnings.
Price-to-Book (P/B) Ratio: The price-to-book ratio compares a company’s share price with its book value per share, which is shareholders’ equity divided by the number of shares. A ratio of 1 means the stock trades at exactly its accounting net worth. The multiple is used widely for valuing banks and other asset-heavy businesses on the EGX.
Dividend Yield: Dividend yield is the annual cash dividend per share expressed as a percentage of the current share price. It measures the income a shareholder receives from distributions relative to the market price of the stock. Because the calculation uses the market price, the yield rises when the price falls and falls when the price rises, assuming the dividend is unchanged.

Frequently asked questions

What is Kahira Pharmaceuticals & Chemical Industries Co. (CPCI) share price today?: Kahira Pharmaceuticals & Chemical Industries Co. last traded at EGP 599.7 on the Egyptian Exchange (as of 28 Oct 2026, 12:50, Cairo time). Prices update every 15 minutes during EGX trading hours.
What is CPCI's market capitalization?: Kahira Pharmaceuticals & Chemical Industries Co. has a market capitalization of about EGP 8.96B.
Does CPCI pay dividends?: Yes — Kahira Pharmaceuticals & Chemical Industries Co. paid EGP 2 per share for fiscal 2019, a dividend yield of 0.33% at the last price.
What is CPCI's P/E ratio?: Kahira Pharmaceuticals & Chemical Industries Co. trades at a trailing price-to-earnings ratio of 16.16.
What sector is Kahira Pharmaceuticals & Chemical Industries Co. in?: Kahira Pharmaceuticals & Chemical Industries Co. is listed on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector.
Where can I track CPCI?: This Starta Markets page shows Kahira Pharmaceuticals & Chemical Industries Co.'s EGX quote (delayed 15 minutes), key statistics, financial statements, dividends, technicals and news, in Arabic and English.